I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 34 studies | 30% ± 10% | |
| natural killer cell | 30 studies | 25% ± 6% | |
| mast cell | 20 studies | 29% ± 8% | |
| classical monocyte | 20 studies | 29% ± 14% | |
| conventional dendritic cell | 18 studies | 31% ± 19% | |
| naive B cell | 18 studies | 33% ± 10% | |
| memory B cell | 17 studies | 32% ± 8% | |
| CD16-positive, CD56-dim natural killer cell, human | 15 studies | 28% ± 7% | |
| monocyte | 15 studies | 27% ± 8% | |
| macrophage | 14 studies | 25% ± 8% | |
| CD16-negative, CD56-bright natural killer cell, human | 12 studies | 30% ± 13% | |
| non-classical monocyte | 10 studies | 25% ± 9% | |
| microglial cell | 10 studies | 33% ± 13% | |
| dendritic cell | 10 studies | 30% ± 13% | |
| myeloid cell | 8 studies | 27% ± 12% | |
| precursor B cell | 7 studies | 48% ± 18% | |
| immature B cell | 6 studies | 52% ± 20% | |
| hematopoietic precursor cell | 5 studies | 46% ± 25% | |
| mature NK T cell | 5 studies | 29% ± 7% | |
| gamma-delta T cell | 5 studies | 25% ± 4% | |
| pro-B cell | 5 studies | 54% ± 12% | |
| leukocyte | 4 studies | 26% ± 8% | |
| hematopoietic stem cell | 4 studies | 30% ± 12% | |
| plasma cell | 4 studies | 24% ± 5% | |
| innate lymphoid cell | 4 studies | 23% ± 4% | |
| plasmablast | 3 studies | 42% ± 29% | |
| common myeloid progenitor | 3 studies | 31% ± 18% | |
| germinal center B cell | 3 studies | 47% ± 9% | |
| mononuclear phagocyte | 3 studies | 29% ± 15% |
